GLP-1 Weight Loss, BMI & BMR Guides

Florida Blue GLP-1 coverage: formulary status for Wegovy and Zepbound, PA criteria, copays, and cheapest alternatives if denied.

Horizon BCBS of New Jersey GLP-1 coverage: formulary status, PA criteria, copays, and cheapest alternatives if denied.

Studies link semaglutide to a small increased risk of NAION — sudden painless vision loss. Who's at risk, the warning signs, and what to do.

Studies link GLP-1 drugs to 40-70% lower dementia risk in diabetics. The neuroscience, the EVOKE trials, and what it means for prevention.

Cannabis and GLP-1 both act on appetite and the gut. The interaction risks — gastroparesis, nausea, blunted weight loss — and what users report.

GLP-1s slow gastric emptying — retained food raises aspiration risk under sedation. When to stop, prep adjustments, and official guidance.

No direct interaction — but caffeine affects nausea, hydration, and appetite on GLP-1. Coffee, energy drinks, and your medication.

Users report spontaneously losing interest in cigarettes on GLP-1 — and early research backs it up. Nicotine, vaping, Zyn, and the cessation evidence.

Eli Lilly's dual GLP-1/glucagon agonist showing ~20% weight loss in phase 3 trials. Mechanism, results vs Zepbound, side effects, and approval timeline.

Millions take both ADHD stimulants and GLP-1s. The real interaction picture: absorption, appetite stacking, heart rate, and what prescribers watch.

Bupropion is already half of the weight-loss drug Contrave — so how does it combine with GLP-1? Safety, appetite stacking, and what prescribers watch.

Rapid weight loss on GLP-1 raises gallstone risk — it's on the label. Who's at risk, the warning signs, prevention, and when it's an emergency.